Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
MR Imaging in Multiple Sclerosis: The Accuracy of 3D Double Inversion Recovery at 3 Tesla and the Potential for Single Sequence Imaging.
T-bet or not T-bet: Taking the last bow on the autoimmunity stage.
Molecular cloning of a human cannabinoid receptor which is also expressed in testis.
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
Iranian family caregivers' challenges and issues in caring of multiple sclerosis patients: A descriptive explorative qualitative study.
Fingolimod treatment in multiple sclerosis leads to increased macular volume.
Pathology and disease mechanisms in different stages of multiple sclerosis.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
Excitotoxic mechanisms of ischemic injury in myelinated white matter.
Response: relationship between vitamin D and depression in multiple sclerosis.
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.
Cognitive Impairment in Multiple Sclerosis.
Modifiable Comorbidities and Disability in Multiple Sclerosis.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis.
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
MRI Mapping of Cerebrovascular Reactivity via Gas Inhalation Challenges.
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
[Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate].
Urinary tract infection in multiple sclerosis: a practical algorithm for a common problem.
Teaching NeuroImages: MRI time lag with acute disseminated encephalomyelitis.
Pages
« first
‹ previous
…
221
222
223
224
225
226
227
228
229
…
next ›
last »